US Patent 7897157 Activatable clostridial toxins

Patent 7897157 was granted and assigned to Allergan, Inc. on March, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Allergan, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

78971570

Patent Inventor Names

Shengwen Li0

Lance E. Steward0

Marcella A. Gilmore0

Sanjiv Ghanshani0

Ester Fernandez-Salas0

J. Oliver Dolly0

Joseph Francis0

Kei Roger Aoki0

Date of Patent

March 1, 2011

Patent Application Number

118452520

Date Filed

August 27, 2007

Patent Primary Examiner

‌

Chih-Min Kam

Patent abstract

Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7897157 Activatable clostridial toxins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API